<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A total of 140 patients with atherosclerotic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> were subjected to a multiple modality treatment </plain></SENT>
<SENT sid="1" pm="."><plain>The efficiency of the treatment with (n-90) and without (n-50) hemosorption was compared </plain></SENT>
<SENT sid="2" pm="."><plain>The results of the treatment were assessed by neurologic and neuropsychological examinations, spectral analysis of the EEG and the study of blood <z:chebi fb="23" ids="18059">lipids</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Hemosorption was found to be highly effective in the treatment of patients with atherosclerotic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo>, which was expressed in the regression of clinical manifestations, a positive time-course of the electrical activity of the brain and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism indicators </plain></SENT>
</text></document>